HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anne-Sophie Alary Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

1/2022RAS activation induces synthetic lethality of MEK inhibition with mitochondrial oxidative metabolism in acute myeloid leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anne-Sophie Alary Research Topics

Disease

4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
04/2024 - 01/2019
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
12/2020 - 10/2019
1Leukemia
04/2022
1Oncogene Addiction
01/2022
1Neoplasms (Cancer)
12/2019
1Iron Overload
10/2019

Drug/Important Bio-Agent (IBA)

1venetoclaxIBA
04/2022
1Azacitidine (5 Azacytidine)FDA Link
04/2022
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2022
1trametinibIBA
01/2022
1IronIBA
10/2019
1RNA Splicing FactorsIBA
10/2019
1alpha-hydroxyglutarateIBA
01/2019

Therapy/Procedure

3Drug Therapy (Chemotherapy)
04/2024 - 12/2020
2Therapeutics
01/2022 - 12/2020
1Salvage Therapy
04/2022
1Hematopoietic Stem Cell Transplantation
12/2019